×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 7.2%
Defense World
Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)'s share price was down 7.2% on Friday . The company traded as low as $11.09 and last...
9 hours ago
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 7.2%
MarketBeat
Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) fell 7.2% during mid-day trading on Friday . The company traded as low as...
2 days ago
Public companies among Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) largest shareholders, saw gain in holdings value after stock jumped 10% last week
Simply Wall Street
Hedge funds don't have many shares in Gyre Therapeutics. Our data shows that GNI Group Ltd. is the largest shareholder with 75% of shares...
1 month ago
Gyre Therapeutics Stock: Under The Radar Biotech Has A Shot At MASH Approval (NASDAQ:GYRE)
Seeking Alpha
Gyre Therapeutics is an under-the-radar biotech company that achieved its listing on the Nasdaq through a merger between Catalyst...
1 month ago
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
markets.businessinsider.com
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) rose...
1 month ago
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 7.5%
Defense World
Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) dropped 7.5% on Friday . The stock traded as low as $14.00 and last traded...
1 week ago
Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and ...
GlobeNewswire
The combined company will operate as “Gyre Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “GYRE” effective...
6 months ago
4Q23 Wrap: Turning up
BioCentury
Biopharma stocks gained across all market cap tiers in 4Q23, though most did not erase losses in earlier quarters to finish the year in the...
4 months ago
Gyre Therapeutics Stock: Little Known Liver Disease Company But Nothing Stands Out (GYRE)
Seeking Alpha
Gyre Therapeutics develops Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH) in the US and...
4 months ago
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day ...
markets.businessinsider.com
Shares of MercadoLibre, Inc. (NASDAQ:MELI) fell sharply during Friday's session after the company reported fourth-quarter financial results.
3 months ago